2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide

C58H110N2O16 — CID 59051987

IUPAC2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide
SMILESCCCCCCCCCCCCCCCCCCNC(=O)CN(CCCCCCCCCCCCCCCCCC)C(=O)CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O
InChIInChI=1S/C58H110N2O16/c1-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-59-45(62)39-60(38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-2)46(63)41-71-58-55(76-57-52(69)50(67)48(65)43(4)73-57)53(70)54(44(40-61)74-58)75-56-51(68)49(66)47(64)42(3)72-56/h42-44,47-58,61,64-70H,5-41H2,1-4H3,(H,59,62)/t42-,43-,44+,47-,48-,49+,50+,51+,52+,53-,54+,55+,56-,57-,58+/m0/s1
InChIKeyCIFWDSRXOYBCHK-BCJOEFLFSA-N
MW1091.52 g/mol
LogP6.97
Rot. Bonds44

About 2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide

2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide (PubChem CID 59051987) has the molecular formula C58H110N2O16 and a molecular weight of 1091.52 g/mol. Its IUPAC name is 2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide.

Molecular Properties

Compound Name2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide
PubChem CID59051987
Molecular FormulaC58H110N2O16
Molecular Weight1091.52 g/mol
Exact Mass1090.79
IUPAC Name2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide
SMILESCCCCCCCCCCCCCCCCCCNC(=O)CN(CCCCCCCCCCCCCCCCCC)C(=O)CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O
InChIInChI=1S/C58H110N2O16/c1-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-59-45(62)39-60(38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-2)46(63)41-71-58-55(76-57-52(69)50(67)48(65)43(4)73-57)53(70)54(44(40-61)74-58)75-56-51(68)49(66)47(64)42(3)72-56/h42-44,47-58,61,64-70H,5-41H2,1-4H3,(H,59,62)/t42-,43-,44+,47-,48-,49+,50+,51+,52+,53-,54+,55+,56-,57-,58+/m0/s1
InChIKeyCIFWDSRXOYBCHK-BCJOEFLFSA-N
XLogP6.97
TPSA266.63 Ų
H-Bond Donors9
H-Bond Acceptors16
Rotatable Bonds44
Heavy Atoms76
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001091.52
LogP ≤ 56.97
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide?
The IUPAC name of 2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide (CID 59051987) is 2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide.
What is the SMILES notation for 2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide?
The canonical SMILES for 2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide is CCCCCCCCCCCCCCCCCCNC(=O)CN(CCCCCCCCCCCCCCCCCC)C(=O)CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O.
What is the InChIKey of 2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide?
The InChIKey is CIFWDSRXOYBCHK-BCJOEFLFSA-N. The full InChI is InChI=1S/C58H110N2O16/c1-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-59-45(62)39-60(38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-2)46(63)41-71-58-55(76-57-52(69)50(67)48(65)43(4)73-57)53(70)54(44(40-61)74-58)75-56-51(68)49(66)47(64)42(3)72-56/h42-44,47-58,61,64-70H,5-41H2,1-4H3,(H,59,62)/t42-,43-,44+,47-,48-,49+,50+,51+,52+,53-,54+,55+,56-,57-,58+/m0/s1.
What are the key properties of 2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide?
2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide has a molecular weight of 1091.52 g/mol, XLogP of 6.97, 44 rotatable bonds, 9 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[2-[(2R,3R,4S,5S,6R)-4-hydroxy-6-(hydroxymethyl)-3,5-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxyacetyl]-octadecylamino]-N-octadecylacetamide is sourced from PubChem (CID 59051987), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).